Innoviva, Inc. is a company in the U.S. stock market and it is a holding in 83 U.S.-traded ETFs. INVA has around 12.9M shares in the U.S. ETF market. The largest ETF holder of INVA is the iShares Core S&P Small-Cap ETF (IJR), with approximately 4.15M shares. Investors may also find of interest that the ETF with the largest allocation to INVA stock is Invesco Dynamic Pharmaceuticals ETF (PJP), with a portfolio weight of 2.44%. On average, U.S. ETFs allocate 0.24% of INVA to their portfolios.
Additionally, INVA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with INVA as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 50.24%.